Pharma Companies Explore Risk-Based Approach For Rapid Decision-Making Within R & D At Bio/Analytical Testing Congress

NEW YORK--(BUSINESS WIRE)--Aug. 23, 2005--Bio/Analytical Testing Congress: On September 19-21 2005, pharmaceutical and biotechnology companies will meet in Philadelphia to discuss how to take a risk-based approach to bioanalytical and analytical testing, methods and processes.
MORE ON THIS TOPIC